Preclinical oral toxicology in rats of D-002, a natural drug with antiulcer effects

Drug and Chemical Toxicology

Volumn 21, Issue 2, 1998, Pages 151-162

  Rodeiro, I ^a   Aleman C ^a   Noa, M ^a   Menendez R ^a   Mas R ^a   Hernandez C ^a   Garcia, M ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; D 002; PROPOLIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; LIVER TOXICITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; TOXICITY TESTING;

ANIMALIA; APIS MELLIFERA; APOIDEA; PROPOLIS;

EID: 0031971166     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549809011644     Document Type: Article

References (16)

1. Brimblecambe, R.W., Leslie, G. B., Walker, T., Toxicology of Cimetidine, Human Tox., 4: 13, 1985.
2. Carlsoon, E., A Review of the Effects of Long-term Acid Inhibition in Animals, Scand. J. Gastroenterol., 24, suppl. 166, 19, 1989.
3. Ekman, L., Hansson, E., Havu, N., Carsson, E. and Lundberg, C, Toxicological Studies on Omeprazole, Scand. J. Gastroenterol., 20, suppl. 108, 53, 1985.
4. Probst, K. S., Higdon, G. L., Fisher, L. F., MacGrath, J. P., Adams, E. R. and Emmerson, J. L, Preclinical Toxicology Studies With Nizatidine, a New H2 Receptor Antagonist: Acute, Subchronic and Chronic Toxicity Evaluations, Fundam. Appl. Toxicol., 13:4, 778, 1989.
5. Weintraub, M. and Evans, P. Misoprostol: New Approach to the Treatment of Peptic Ulcer Disease, Hosp. Formul., 22:704, 1987.
6. Carbajal, D., Molina, V., Valdes, S., Arruzazabala, L., Mas, R. and Magraner, J. Anti-inflammatory Activity of D-002: An Active Product Isolated From Bees Wax. Prostaglandins, Leukotrienes and Essential Fatty Acids, in press, 1995.
7. Carbajal, D., Molina, V., Valdes, S., Arruzazabala, L., Rodeiro, I., Mas, R and Magraner, J. Possible Mechanism Cytoprotective of D-002. An Antiulcerogenic Product Isolated From Beeswax, J. of Pharmacy and Pharmacology, 48:858, 1996.
8. Carbajal, D., Molina, V., Arruzazabala, L, Valdes, S., Mas, R. Effect of D-002: An Active Product Isolated From Bees wax on Experimentally Induced Ulcers, J. of Pharmacy and Pharmacology, 47:9, 731, 1995.
9. Rodeiro, I., Alemán, C., Más, R., Noa, M., Briñis, F. and Hernández, C, Toxicología Aguda Oral Del D-002 En Ratas Sprague-Dawley, Revista CENIC, Ciencias Biológicas, 26, 1-2-3, 34, 1995.
10. Wilson, A. B, Effects of Physical Form, Route and Species in "Experimental Toxicology, the Basic Issues", 2nd edition, 1993, cap. 2, p. 5.
11. Stevens, K. R. and Gallo, M. A, Practical Considerations in the Conduct of Chronic Toxicity Studies, in "Principles and Methods in Toxicology", Hayes, A.W. eds., Raven press, New York, 1989, p. 53.
12. Chhabra, R. S., Huff, J. E., Scwetz, B. S. and Selkirk, J. An Overview of Prechronic and Chronic Toxicity/Carcinogenicity Experimental Study Designs and Criteria Used by the National Toxicology Program (NTP), 1990.
13. Gad, S. C. and Weil, C. S. Statistic for Toxicologist, J. of the American College of Toxicology, 7:2, 1988.
14. Aleman, C., Mas, R., Rodeiro, I., Noa, M., Hernandez, C., Menendez, R., Gamez, R., Reference Data Base of the Main Physiological Parameters in Sprague-Dawley Rats From 6 to 32 Months, Laboratory Animals, in press, 1997.
15. Kabir, Y. and Kimura, S., Biodistribution and Metabolism of Orally Administered Octacosanol in Rats, Annals of Nutrition and Metabolism, 37:33, 1993.
16. 14C)-octacosanol in Liver and Muscle of Rats After Serial Administration, Annals of Nutrition and Metabolism, 39:279, 1995.